Blue Sail Medical: Subsidiary Lithonic Coronary Artery Intravascular Shock Wave Therapy System Obtains CE Certificate

Blue Sail Medical announced that its subsidiary Biosensors Interventional Technologies Pte. Ltd.'s Lithonic Coronary Intravascular Shock Wave Therapy System has obtained EU CE certification. The product is used for pre-treatment of severely calcified narrow sites, reducing the risk of complications such as vessel perforation and no-reflow. This certification not only signifies international recognition of the technology but also consolidates the company's technological advantage in the field of coronary arteries, with positive impacts expected on the company's business development. However, sales of medical devices are influenced by market conditions, so investors need to exercise caution when investing.